EGF Ointment for Erlotinib Skin Lesion
This study has been completed.
Dong-A University Hospital
Information provided by (Responsible Party):
Sung Yong Oh, Dong-A University Hospital
First received: May 5, 2012
Last updated: November 2, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2014|
|Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Hwang IG, Kang JH, Oh SY, Lee S, Kim SH, Song KH, Son C, Park MJ, Kang MH, Kim HG, Lee J, Park YS, Sun JM, Kim HJ, Kim CK, Yi SY, Jang JS, Park K, Kim HJ. Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects. Support Care Cancer. 2016 Jan;24(1):301-9. doi: 10.1007/s00520-015-2783-9. Epub 2015 Jun 4.